{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:38:36Z","timestamp":1763599116200,"version":"3.45.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Diagnostic Radiology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1067\/j.cpradiol.2025.08.002","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T15:06:13Z","timestamp":1754665573000},"page":"148-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disparities in MRI and TRUS for prostate cancer detection: A systematic review and meta-analysis of 94,020 cases"],"prefix":"10.1067","volume":"55","author":[{"given":"Ashkan","family":"Bahrami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long H.","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milad","family":"Ghanikolahloo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohreh","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Tafazolimoghadam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahan","family":"Farzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mobina","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaser","family":"Khakpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arian","family":"Tavasol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milad","family":"Alipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Shoja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mobin","family":"Azami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramtin","family":"Hajibeygi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samra","family":"Iftikhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1067\/j.cpradiol.2025.08.002_bib0001","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.3390\/molecules27175730","article-title":"Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches","volume":"27","author":"Sekhoacha","year":"2022","journal-title":"Molecules"},{"issue":"3","key":"10.1067\/j.cpradiol.2025.08.002_bib0002","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: cancer j clin"},{"issue":"1","key":"10.1067\/j.cpradiol.2025.08.002_bib0003","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","article-title":"Recent global patterns in prostate cancer incidence and mortality rates","volume":"77","author":"Culp","year":"2020","journal-title":"Eur urol"},{"issue":"7","key":"10.1067\/j.cpradiol.2025.08.002_bib0004","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/onco.13749","article-title":"Prostate cancer: community education and disparities in diagnosis and treatment","volume":"26","author":"Carthon","year":"2021","journal-title":"Oncologist"},{"key":"10.1067\/j.cpradiol.2025.08.002_bib0005","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1007\/s00261-017-1058-y","article-title":"Assessment of prostate cancer aggressiveness using apparent diffusion coefficient values: impact of patient race and age","volume":"42","author":"Tamada","year":"2017","journal-title":"Abdom Radiol"},{"issue":"8","key":"10.1067\/j.cpradiol.2025.08.002_bib0006","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1002\/cam4.2149","article-title":"Barriers to obtaining prostate multi-parametric magnetic resonance imaging in African-American men on active surveillance for prostate cancer","volume":"8","author":"Walton","year":"2019","journal-title":"Cancer Med"},{"key":"10.1067\/j.cpradiol.2025.08.002_bib0007","article-title":"PSMA PET\/CT for primary staging of prostate cancer-an updated overview","author":"Jochumsen","year":"2023","journal-title":"Seminars in Nuclear Medicine"},{"key":"10.1067\/j.cpradiol.2025.08.002_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2021.06.004","article-title":"The Stanford Prostate Cancer Calculator: development and external validation of online nomograms incorporating PIRADS scores to predict clinically significant prostate cancer","author":"Wang","year":"2021","journal-title":"Urologic Oncology: Seminars and Original Investigations"},{"issue":"7","key":"10.1067\/j.cpradiol.2025.08.002_bib0009","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.acra.2021.03.012","article-title":"A systematic review for health disparities and inequities in multiparametric magnetic resonance imaging for prostate cancer diagnosis","volume":"28","author":"El Khoury","year":"2021","journal-title":"Acad Radiol"},{"key":"10.1067\/j.cpradiol.2025.08.002_bib0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.8116","article-title":"Mediators of racial disparity in the use of prostate magnetic resonance imaging among patients with prostate cancer","author":"Leapman","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1067\/j.cpradiol.2025.08.002_bib0011","doi-asserted-by":"crossref","DOI":"10.1097\/JU.0000000000000774","article-title":"Staging accuracy of multiparametric MRI in Caucasian and African American patients undergoing radical prostatectomy","author":"Falagario","year":"2020","journal-title":"J Urol"},{"issue":"10","key":"10.1067\/j.cpradiol.2025.08.002_bib0012","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1067\/j.cpradiol.2025.08.002_bib0013","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1214\/aoms\/1177729756","article-title":"Transformations related to the angular and the square root","volume":"21","author":"Freeman","year":"1950","journal-title":"Ann Math Stat"},{"issue":"4","key":"10.1067\/j.cpradiol.2025.08.002_bib0014","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"issue":"7109","key":"10.1067\/j.cpradiol.2025.08.002_bib0015","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1067\/j.cpradiol.2025.08.002_bib0016","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1067\/j.cpradiol.2025.08.002_bib0017","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jamaoncol.2020.7589","article-title":"Comparison of multiparametric magnetic resonance imaging\u2013targeted biopsy with systematic transrectal ultrasonography biopsy for biopsy-naive men at risk for prostate cancer: a phase 3 randomized clinical trial","volume":"7","author":"Klotz","year":"2021","journal-title":"JAMA oncol"},{"issue":"7","key":"10.1067\/j.cpradiol.2025.08.002_bib0018","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.urolonc.2015.03.010","article-title":"Differential post-prostatectomy cancer-specific survival of occult T3 vs. clinical T3 prostate cancer: implications for managing patients upstaged on prostate magnetic resonance imaging","volume":"33","author":"Muralidhar","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1067\/j.cpradiol.2025.08.002_bib0019","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s11255-016-1336-6","article-title":"Midline lesions of the prostate: role of MRI\/TRUS fusion biopsy and implications in Gleason risk stratification","volume":"48","author":"Muthigi","year":"2016","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"10.1067\/j.cpradiol.2025.08.002_bib0020","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.euf.2019.03.016","article-title":"Contemporary trends in magnetic resonance imaging at the time of prostate biopsy: results from a large private insurance database","volume":"7","author":"Kim","year":"2021","journal-title":"Eur Urol Focus"},{"issue":"5","key":"10.1067\/j.cpradiol.2025.08.002_bib0021","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jamaoncol.2021.8116","article-title":"Mediators of racial disparity in the use of prostate Magnetic resonance imaging among patients with prostate cancer","volume":"8","author":"Leapman","year":"2022","journal-title":"JAMA Oncol"},{"issue":"11","key":"10.1067\/j.cpradiol.2025.08.002_bib0022","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.32388","article-title":"Racial and ethnic disparities in the use of prostate magnetic resonance imaging following an elevated prostate-specific antigen test","volume":"4","author":"Abashidze","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"FEB","key":"10.1067\/j.cpradiol.2025.08.002_bib0023","article-title":"Mri-derived restriction spectrum imaging cellularity index is associated with high grade prostate cancer on radical prostatectomy specimens","volume":"5","author":"Liss","year":"2015","journal-title":"Front Oncol"},{"key":"10.1067\/j.cpradiol.2025.08.002_bib0024","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s11255-019-02158-6","article-title":"Observed racial disparity in the negative predictive value of multi-parametric MRI for the diagnosis for prostate cancer","volume":"51","author":"Mahran","year":"2019","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"10.1067\/j.cpradiol.2025.08.002_bib0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-5347(06)00493-9","article-title":"Impact of increased number of biopsies on the nature of prostate cancer identified","volume":"176","author":"Meng","year":"2006","journal-title":"J urol"},{"issue":"1","key":"10.1067\/j.cpradiol.2025.08.002_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12894-022-01066-9","article-title":"Assessing the accuracy of multiparametric MRI to predict clinically significant prostate cancer in biopsy na\u00efve men across racial\/ethnic groups","volume":"22","author":"Meza","year":"2022","journal-title":"BMC urol"},{"year":"2015","author":"Muralidhar","series-title":"Differential Post-prostatectomy Cancer-specific Survival of Occult T3 vs. clinical T3 Prostate Cancer: Implications for Managing Patients Upstaged on Prostate Magnetic Resonance Imaging","key":"10.1067\/j.cpradiol.2025.08.002_bib0027"},{"issue":"12","key":"10.1067\/j.cpradiol.2025.08.002_bib0028","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jacr.2022.08.013","article-title":"Radiologists\u2019 contribution to variation in detecting clinically significant prostate cancer in men with prostate MRI","volume":"19","author":"Naik","year":"2022","journal-title":"J Am Coll Radiol"},{"issue":"1","key":"10.1067\/j.cpradiol.2025.08.002_bib0029","first-page":"E22","article-title":"Predictors of prostate bed recurrence on magnetic resonance imaging in patients with rising prostate-specific antigen after radical prostatectomy","volume":"15","author":"Nasser","year":"2021","journal-title":"Can Urol Assoc J"},{"issue":"12","key":"10.1067\/j.cpradiol.2025.08.002_bib0030","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3390\/life11121432","article-title":"Considering predictive factors in the diagnosis of clinically significant prostate cancer in patients with PI-RADS 3 lesions","volume":"11","author":"Natale","year":"2021","journal-title":"Life"},{"key":"10.1067\/j.cpradiol.2025.08.002_bib0031","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.euros.2022.04.017","volume":"41","author":"Parekh","year":"2022","journal-title":"Eur Urol Open Sci"},{"key":"10.1067\/j.cpradiol.2025.08.002_bib0032","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.urology.2021.07.005","article-title":"African American men have increased risk of prostate cancer detection despite similar rates of anterior prostatic lesions and PI-RADS grade on multiparametric magnetic resonance imaging","volume":"163","author":"Patel","year":"2022","journal-title":"Urology"},{"issue":"5","key":"10.1067\/j.cpradiol.2025.08.002_bib0033","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0090-4295(02)01882-4","article-title":"Predicting the outcome of prostate biopsy in a racially diverse population: a prospective study","volume":"60","author":"Porter","year":"2002","journal-title":"Urology"},{"issue":"16","key":"10.1067\/j.cpradiol.2025.08.002_bib0034","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1002\/cncr.33518","article-title":"Disparities in magnetic resonance imaging of the prostate for traditionally underserved patients with prostate cancer","volume":"127","author":"Quinn","year":"2021","journal-title":"Cancer"},{"issue":"9","key":"10.1067\/j.cpradiol.2025.08.002_bib0035","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/pros.24344","article-title":"Prostate MRI percentage tumor involvement or \u201cPI-RADS percent\u201d as a predictor of adverse surgical pathology","volume":"82","author":"Ratnani","year":"2022","journal-title":"Prostate"},{"year":"2021","author":"Wang","series-title":"The Stanford Prostate Cancer Calculator: Development and External Validation of Online Nomograms Incorporating PIRADS Scores to Predict Clinically Significant Prostate Cancer","key":"10.1067\/j.cpradiol.2025.08.002_bib0036"},{"issue":"11","key":"10.1067\/j.cpradiol.2025.08.002_bib0037","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/pros.24174","article-title":"Clinical characteristics and oncological outcomes in negative multiparametric MRI patients undergoing robot-assisted radical prostatectomy","volume":"81","author":"Wagaskar","year":"2021","journal-title":"Prostate"},{"unstructured":"Sundi D., Kryvenko O.N., Carter H.B., et al. Pathologic examination of radical prostatectomies in men with very-low-risk disease at biopsy reveals distinct zonal distribution of cancer in African American men. J Urol.","key":"10.1067\/j.cpradiol.2025.08.002_bib0038"},{"key":"10.1067\/j.cpradiol.2025.08.002_bib0039","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s11255-016-1407-8","article-title":"The impact of African American race on prostate cancer detection on repeat prostate biopsy in a veteran population","volume":"48","author":"Sterling","year":"2016","journal-title":"Int urol nephrol"},{"issue":"2","key":"10.1067\/j.cpradiol.2025.08.002_bib0040","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/bju.13786","article-title":"Detection of prostate cancer using magnetic resonance imaging\/ultrasonography image-fusion targeted biopsy in African-American men","volume":"120","author":"Shin","year":"2017","journal-title":"BJU int"},{"doi-asserted-by":"crossref","unstructured":"Zabihollahy F., Miao Q., Sonni I., et al. Racial disparities in quantitative MRI for African American and white men with prostate cancer. 2023.","key":"10.1067\/j.cpradiol.2025.08.002_bib0041","DOI":"10.21203\/rs.3.rs-2547854\/v1"},{"issue":"11","key":"10.1067\/j.cpradiol.2025.08.002_bib0042","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/cncr.30548","article-title":"Rais-Bahrami S. Factors predicting prostate cancer upgrading on magnetic resonance imaging\u2013targeted biopsy in an active surveillance population","volume":"123","author":"Lai","year":"2017","journal-title":"Cancer"},{"issue":"9","key":"10.1067\/j.cpradiol.2025.08.002_bib0043","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamasurg.2019.1734","article-title":"Comparison of targeted vs systematic prostate biopsy in men who are biopsy naive: the prospective assessment of image registration in the diagnosis of prostate cancer (PAIREDCAP) study","volume":"154","author":"Elkhoury","year":"2019","journal-title":"JAMA surg"},{"issue":"5","key":"10.1067\/j.cpradiol.2025.08.002_bib0044","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jamaoncol.2021.8116","article-title":"Mediators of racial disparity in the use of prostate magnetic resonance imaging among patients with prostate cancer","volume":"8","author":"Leapman","year":"2022","journal-title":"JAMA oncol"},{"issue":"4","key":"10.1067\/j.cpradiol.2025.08.002_bib0045","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41391-020-0223-5","article-title":"Racial disparity in the utilization of multiparametric MRI\u2013ultrasound fusion biopsy for the detection of prostate cancer","volume":"23","author":"Hoge","year":"2020","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"10.1067\/j.cpradiol.2025.08.002_bib0046","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41391-018-0107-0","article-title":"Rais-Bahrami S. Comparison of biparametric MRI to full multiparametric MRI for detection of clinically significant prostate cancer","volume":"22","author":"Sherrer","year":"2019","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"10.1067\/j.cpradiol.2025.08.002_bib0047","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.juro.2007.03.035","article-title":"Decrease in racial disparities in the staging evaluation for prostate cancer after publication of staging guidelines","volume":"178","author":"Abraham","year":"2007","journal-title":"J urol"},{"issue":"4","key":"10.1067\/j.cpradiol.2025.08.002_bib0048","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.adro.2016.07.003","article-title":"Disparities in staging prostate magnetic resonance imaging utilization for nonmetastatic prostate cancer patients undergoing definitive radiation therapy","volume":"1","author":"Ajayi","year":"2016","journal-title":"Adv Radiat Oncol"},{"issue":"5","key":"10.1067\/j.cpradiol.2025.08.002_bib0049","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/bju.14835","article-title":"Use of multiparmetric MRI and fusion-guided biopsies to properly select and follow African-American men on active surveillance","volume":"124","author":"Bloom","year":"2019","journal-title":"BJU int"},{"year":"2020","series-title":"Prospective Development of a Prostate Cancer Risk Calculator in a Racially Diverse Population: the Kaiser Permanente Prostate Cancer Risk Calculator","key":"10.1067\/j.cpradiol.2025.08.002_bib0050"},{"issue":"1","key":"10.1067\/j.cpradiol.2025.08.002_bib0051","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-5347(06)00493-9","article-title":"Impact of increased number of biopsies on the nature of prostate cancer identified","volume":"176","author":"Meng","year":"2006","journal-title":"J Urol"},{"issue":"11","key":"10.1067\/j.cpradiol.2025.08.002_bib0052","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.urolonc.2020.05.011","article-title":"Prospective development of a prostate cancer risk calculator in a racially diverse population: the Kaiser Permanente Prostate cancer risk Calculator","volume":"38","author":"Presti","year":"2020","journal-title":"Urol Oncol"},{"issue":"8","key":"10.1067\/j.cpradiol.2025.08.002_bib0053","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1002\/cam4.2149","article-title":"Barriers to obtaining prostate multi-parametric magnetic resonance imaging in African-American men on active surveillance for prostate cancer","volume":"8","author":"Walton","year":"2019","journal-title":"Cancer Med"},{"issue":"4","key":"10.1067\/j.cpradiol.2025.08.002_bib0054","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.adro.2016.07.003","article-title":"Disparities in staging prostate magnetic resonance imaging utilization for nonmetastatic prostate cancer patients undergoing definitive radiation therapy","volume":"1","author":"Ajayi","year":"2016","journal-title":"Adv Radiat Oncol"},{"issue":"5","key":"10.1067\/j.cpradiol.2025.08.002_bib0055","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jamaoncol.2021.8116","article-title":"Mediators of racial disparity in the use of prostate magnetic resonance imaging among patients with prostate cancer","volume":"8","author":"Leapman","year":"2022","journal-title":"JAMA Oncol"},{"issue":"12","key":"10.1067\/j.cpradiol.2025.08.002_bib0056","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s11255-016-1407-8","article-title":"The impact of African American race on prostate cancer detection on repeat prostate biopsy in a veteran population","volume":"48","author":"Sterling","year":"2016","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"10.1067\/j.cpradiol.2025.08.002_bib0057","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2214\/AJR.20.23462","article-title":"Increasing utilization of MRI before prostate biopsy in Black and non-Black men: an analysis of the SEER-Medicare cohort","volume":"217","author":"Gaffney","year":"2021","journal-title":"Am J Roentgenol"},{"issue":"2","key":"10.1067\/j.cpradiol.2025.08.002_bib0058","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/bju.13786","article-title":"Detection of prostate cancer using magnetic resonance imaging\/ultrasonography image-fusion targeted biopsy in African-American men","volume":"120","author":"Shin","year":"2017","journal-title":"BJU Int"},{"issue":"8","key":"10.1067\/j.cpradiol.2025.08.002_bib0059","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s11255-019-02158-6","article-title":"Observed racial disparity in the negative predictive value of multi-parametric MRI for the diagnosis for prostate cancer","volume":"51","author":"Mahran","year":"2019","journal-title":"Int Urol Nephrol"},{"issue":"8","key":"10.1067\/j.cpradiol.2025.08.002_bib0060","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s11255-019-02158-6","article-title":"Observed racial disparity in the negative predictive value of multi-parametric MRI for the diagnosis for prostate cancer","volume":"51","author":"Mahran","year":"2019","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"10.1067\/j.cpradiol.2025.08.002_bib0061","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12894-022-01066-9","article-title":"Assessing the accuracy of multiparametric MRI to predict clinically significant prostate cancer in biopsy na\u00efve men across racial\/ethnic groups","volume":"22","author":"Meza","year":"2022","journal-title":"BMC Urol"},{"issue":"12","key":"10.1067\/j.cpradiol.2025.08.002_bib0062","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.urolonc.2021.06.004","article-title":"The stanford prostate cancer calculator: development and external validation of online nomograms incorporating PIRADS scores to predict clinically significant prostate cancer","volume":"39","author":"Wang","year":"2021","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1067\/j.cpradiol.2025.08.002_bib0063","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/UPJ.0000000000000435","article-title":"An examination of racial and ethnic disparities in the use of prostate biopsy and magnetic resonance imaging in prostate cancer screening","volume":"10","author":"Chartrand","year":"2023","journal-title":"Urol Pr"},{"issue":"12","key":"10.1067\/j.cpradiol.2025.08.002_bib0064","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/jnci\/djaa034","article-title":"Ethnic disparities in imaging utilization at diagnosis of non-small cell lung cancer","volume":"112","author":"Morgan","year":"2020","journal-title":"JNCI: J Natl Cancer Inst"},{"issue":"9","key":"10.1067\/j.cpradiol.2025.08.002_bib0065","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jacr.2012.05.005","article-title":"Geographic and sociodemographic disparities in PET use by Medicare beneficiaries with cancer","volume":"9","author":"Onega","year":"2012","journal-title":"J Am Coll Radiol"},{"key":"10.1067\/j.cpradiol.2025.08.002_bib0066","first-page":"1721","article-title":"Does socioeconomic disparity in cancer incidence vary across racial\/ethnic groups?","volume":"21","author":"Yin","year":"2010","journal-title":"Cancer Causes Control"},{"issue":"1","key":"10.1067\/j.cpradiol.2025.08.002_bib0067","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/jamaoncol.2015.3384","article-title":"Racial differences in the surgical care of Medicare beneficiaries with localized prostate cancer","volume":"2","author":"Schmid","year":"2016","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1067\/j.cpradiol.2025.08.002_bib0068","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20471","article-title":"Trends in the use of stereotactic body radiotherapy for treatment of prostate cancer in the United States","volume":"3","author":"Mahase","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1067\/j.cpradiol.2025.08.002_bib0069","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.urology.2012.12.046","article-title":"Increased incidence of pathologically nonorgan confined prostate cancer in African-American men eligible for active surveillance","volume":"81","author":"Ha","year":"2013","journal-title":"Urology"},{"issue":"10","key":"10.1067\/j.cpradiol.2025.08.002_bib0070","first-page":"1721","article-title":"Does socioeconomic disparity in cancer incidence vary across racial\/ethnic groups?","volume":"21","author":"Yin","year":"2010","journal-title":"Cancer Causes Control"},{"issue":"5","key":"10.1067\/j.cpradiol.2025.08.002_bib0071","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/annonc\/mdx041","article-title":"Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States","volume":"28","author":"Mahal","year":"2017","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1067\/j.cpradiol.2025.08.002_bib0072","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jacr.2018.07.009","article-title":"National private payer coverage of prostate MRI","volume":"16","author":"Booker","year":"2019","journal-title":"J Am Coll Radiol"},{"issue":"8","key":"10.1067\/j.cpradiol.2025.08.002_bib0073","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.acra.2015.02.006","article-title":"Prostate MRI can reduce overdiagnosis and overtreatment of prostate cancer","volume":"22","author":"Rosenkrantz","year":"2015","journal-title":"Acad Radiol"},{"issue":"5s","key":"10.1067\/j.cpradiol.2025.08.002_bib0074","doi-asserted-by":"crossref","first-page":"620","DOI":"10.6004\/jnccn.2018.0036","article-title":"NCCN guidelines updates: prostate cancer and prostate cancer early detection","volume":"16","author":"Carroll","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1067\/j.cpradiol.2025.08.002_bib0075","article-title":"Racial disparities in quantitative MRI for African American and white men with","author":"Zabihollahy","year":"2023","journal-title":"Prostate Cancer Res Sq"},{"issue":"1","key":"10.1067\/j.cpradiol.2025.08.002_bib0076","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12894-022-01066-9","article-title":"Assessing the accuracy of multiparametric MRI to predict clinically significant prostate cancer in biopsy na\u00efve men across racial\/ethnic groups","volume":"22","author":"Meza","year":"2022","journal-title":"BMC urol"},{"issue":"5","key":"10.1067\/j.cpradiol.2025.08.002_bib0077","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jamaoncol.2021.8116","article-title":"Mediators of racial disparity in the use of prostate Magnetic resonance imaging among patients with prostate cancer","volume":"8","author":"Leapman","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1067\/j.cpradiol.2025.08.002_bib0078","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.euros.2022.04.017","volume":"41","author":"Parekh","year":"2022","journal-title":"Eur Urol Open Sci"},{"key":"10.1067\/j.cpradiol.2025.08.002_bib0079","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.urology.2021.07.005","article-title":"African American men have increased risk of prostate cancer detection despite similar rates of anterior prostatic lesions and PI-RADS grade on multiparametric Magnetic resonance imaging","volume":"163","author":"Patel","year":"2022","journal-title":"Urology"},{"issue":"9","key":"10.1067\/j.cpradiol.2025.08.002_bib0080","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/pros.24344","article-title":"Prostate MRI percentage tumor involvement or \u201cPI-RADS percent\u201d as a predictor of adverse surgical pathology","volume":"82","author":"Ratnani","year":"2022","journal-title":"Prostate"},{"year":"2021","series-title":"The Stanford Prostate Cancer Calculator: Development and External Validation of Online Nomograms Incorporating PIRADS Scores to Predict Clinically Significant Prostate Cancer","key":"10.1067\/j.cpradiol.2025.08.002_bib0081"},{"issue":"1","key":"10.1067\/j.cpradiol.2025.08.002_bib0082","first-page":"E22","article-title":"Predictors of prostate bed recurrence on magnetic resonance imaging in patients with rising prostate-specific antigen after radical prostatectomy","volume":"15","author":"Nasser","year":"2021","journal-title":"Can Urol Assoc J"},{"issue":"12","key":"10.1067\/j.cpradiol.2025.08.002_bib0083","article-title":"Considering predictive factors in the diagnosis of clinically significant prostate cancer in patients with PI-RADS 3 lesions","volume":"11","author":"Natale","year":"2021","journal-title":"Life (Basel)"},{"issue":"16","key":"10.1067\/j.cpradiol.2025.08.002_bib0084","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1002\/cncr.33518","article-title":"Disparities in magnetic resonance imaging of the prostate for traditionally underserved patients with prostate cancer","volume":"127","author":"Quinn","year":"2021","journal-title":"Cancer"},{"issue":"11","key":"10.1067\/j.cpradiol.2025.08.002_bib0085","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.32388","article-title":"Racial and ethnic disparities in the use of prostate magnetic resonance imaging following an elevated prostate-specific antigen test","volume":"4","author":"Abashidze","year":"2021","journal-title":"JAMA netw open"},{"issue":"12","key":"10.1067\/j.cpradiol.2025.08.002_bib0086","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.urolonc.2021.06.004","article-title":"The stanford prostate cancer calculator: development and external validation of online nomograms incorporating PIRADS scores to predict clinically significant prostate cancer","volume":"39","author":"Wang","year":"2021","journal-title":"Urol Oncol"},{"issue":"11","key":"10.1067\/j.cpradiol.2025.08.002_bib0087","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/pros.24174","article-title":"Clinical characteristics and oncological outcomes in negative multiparametric MRI patients undergoing robot-assisted radical prostatectomy","volume":"81","author":"Wagaskar","year":"2021","journal-title":"Prostate"},{"issue":"5","key":"10.1067\/j.cpradiol.2025.08.002_bib0088","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/bju.14835","article-title":"Use of multiparametric magnetic resonance imaging and fusion-guided biopsies to properly select and follow African-American men on active surveillance","volume":"124","author":"Bloom","year":"2019","journal-title":"BJU Int"},{"issue":"4","key":"10.1067\/j.cpradiol.2025.08.002_bib0089","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jamaoncol.2020.7589","article-title":"Comparison of multiparametric magnetic resonance imaging-targeted biopsy with systematic transrectal ultrasonography biopsy for biopsy-naive men at risk for prostate cancer: a phase 3 randomized clinical trial","volume":"7","author":"Klotz","year":"2021","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1067\/j.cpradiol.2025.08.002_bib0090","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41391-020-0223-5","article-title":"Racial disparity in the utilization of multiparametric MRI\u2013ultrasound fusion biopsy for the detection of prostate cancer","volume":"23","author":"Hoge","year":"2020","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"11","key":"10.1067\/j.cpradiol.2025.08.002_bib0091","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.urolonc.2020.05.011","article-title":"Prospective development of a prostate cancer risk calculator in a racially diverse population: the Kaiser Permanente Prostate cancer risk Calculator","volume":"38","author":"Presti","year":"2020","journal-title":"Urol Oncol"},{"issue":"8","key":"10.1067\/j.cpradiol.2025.08.002_bib0092","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1002\/cam4.2149","article-title":"Barriers to obtaining prostate multi-parametric magnetic resonance imaging in African-American men on active surveillance for prostate cancer","volume":"8","author":"Walton","year":"2019","journal-title":"Cancer Med"},{"issue":"2","key":"10.1067\/j.cpradiol.2025.08.002_bib0093","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41391-018-0107-0","article-title":"Rais-Bahrami S. Comparison of biparametric MRI to full multiparametric MRI for detection of clinically significant prostate cancer","volume":"22","author":"Sherrer","year":"2019","journal-title":"Prostate cancer prostatic dis"},{"issue":"9","key":"10.1067\/j.cpradiol.2025.08.002_bib0094","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamasurg.2019.1734","article-title":"Comparison of targeted vs systematic prostate biopsy in men who are biopsy naive: the prospective assessment of image registration in the diagnosis of prostate cancer (PAIREDCAP) study","volume":"154","author":"Elkhoury","year":"2019","journal-title":"JAMA surg"},{"key":"10.1067\/j.cpradiol.2025.08.002_bib0095","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s11255-019-02158-6","article-title":"Observed racial disparity in the negative predictive value of multi-parametric MRI for the diagnosis for prostate cancer","volume":"51","author":"Mahran","year":"2019","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"10.1067\/j.cpradiol.2025.08.002_bib0096","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.euf.2019.03.016","article-title":"Contemporary trends in magnetic resonance imaging at the time of prostate biopsy: results from a large private insurance database","volume":"7","author":"Kim","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1067\/j.cpradiol.2025.08.002_bib0097","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1007\/s00261-017-1058-y","article-title":"Assessment of prostate cancer aggressiveness using apparent diffusion coefficient values: impact of patient race and age","volume":"42","author":"Tamada","year":"2017","journal-title":"Abdom Radiol"},{"issue":"11","key":"10.1067\/j.cpradiol.2025.08.002_bib0098","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/cncr.30548","article-title":"Rais-Bahrami S. Factors predicting prostate cancer upgrading on magnetic resonance imaging\u2013targeted biopsy in an active surveillance population","volume":"123","author":"Lai","year":"2017","journal-title":"Cancer"},{"issue":"2","key":"10.1067\/j.cpradiol.2025.08.002_bib0099","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/bju.13786","article-title":"Detection of prostate cancer using magnetic resonance imaging\/ultrasonography image-fusion targeted biopsy in African-American men","volume":"120","author":"Shin","year":"2017","journal-title":"BJU int"},{"key":"10.1067\/j.cpradiol.2025.08.002_bib0100","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s11255-016-1336-6","article-title":"Midline lesions of the prostate: role of MRI\/TRUS fusion biopsy and implications in Gleason risk stratification","volume":"48","author":"Muthigi","year":"2016","journal-title":"Int urol nephrol"},{"issue":"4","key":"10.1067\/j.cpradiol.2025.08.002_bib0101","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.adro.2016.07.003","article-title":"Disparities in staging prostate magnetic resonance imaging utilization for nonmetastatic prostate cancer patients undergoing definitive radiation therapy","volume":"1","author":"Ajayi","year":"2016","journal-title":"Adv Radiat Oncol"},{"key":"10.1067\/j.cpradiol.2025.08.002_bib0102","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s11255-016-1407-8","article-title":"The impact of African American race on prostate cancer detection on repeat prostate biopsy in a veteran population","volume":"48","author":"Sterling","year":"2016","journal-title":"Int urol nephrol"},{"year":"2015","series-title":"Differential Post-Prostatectomy Cancer-specific Survival of Occult T3 vs. Clinical T3 Prostate Cancer: Implications for Managing Patients Upstaged on Prostate Magnetic Resonance Imaging","key":"10.1067\/j.cpradiol.2025.08.002_bib0103"},{"key":"10.1067\/j.cpradiol.2025.08.002_bib0104","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fonc.2015.00030","article-title":"MRI-derived restriction spectrum imaging cellularity index is associated with high grade prostate cancer on radical prostatectomy specimens","volume":"5","author":"Liss","year":"2015","journal-title":"Front Oncol"},{"unstructured":"Sundi D., Kryvenko O.N., Carter H.B., et al. Pathologic examination of radical prostatectomies in men with very-low-risk disease at biopsy reveals distinct zonal distribution of cancer in African American men. J Urol.","key":"10.1067\/j.cpradiol.2025.08.002_bib0105"},{"issue":"1","key":"10.1067\/j.cpradiol.2025.08.002_bib0106","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-5347(06)00493-9","article-title":"Impact of increased number of biopsies on the nature of prostate cancer identified","volume":"176","author":"Meng","year":"2006","journal-title":"J urol"},{"issue":"5","key":"10.1067\/j.cpradiol.2025.08.002_bib0107","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0090-4295(02)01882-4","article-title":"Predicting the outcome of prostate biopsy in a racially diverse population: a prospective study","volume":"60","author":"Porter","year":"2002","journal-title":"Urology"}],"container-title":["Current Problems in Diagnostic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0363018825001483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0363018825001483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:35:29Z","timestamp":1763598929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0363018825001483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":107,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0363018825001483"],"URL":"https:\/\/doi.org\/10.1067\/j.cpradiol.2025.08.002","relation":{},"ISSN":["0363-0188"],"issn-type":[{"type":"print","value":"0363-0188"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disparities in MRI and TRUS for prostate cancer detection: A systematic review and meta-analysis of 94,020 cases","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Diagnostic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1067\/j.cpradiol.2025.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}